Article Text

Download PDFPDF

979 Characterization of T cell specificity and exercise-induced dynamics of soluble immunological markers before and after high-intensity aerobic exercise (INHALE)
  1. Katharina Leuchte1,
  2. Thy Luu2,
  3. Sara Fresnillo Saló2,
  4. Signe Skadborg3,
  5. Janine Kemming3,
  6. Anders Vinther4,5,
  7. Sine Reker Hadrup6,
  8. Per thor Straten2 and
  9. Gitte Holmen Olofsson2
  1. 1Herlev Hospital, Herlev, Denmark
  2. 2National Center For Cancer Immune Therapy (CCIT), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark
  3. 3Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark
  4. 4Department of Physiotherapy and Occupational Therapy, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark
  5. 5Hospital Secretariat and Communications, Research, Herlev, Denmark
  6. 6Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark
  • Journal for ImmunoTherapy of Cancer (JITC) preprint. The copyright holder for this preprint are the authors/funders, who have granted JITC permission to display the preprint. All rights reserved. No reuse allowed without permission.

Abstract

Background Exercise enhances immunosurveillance and prevents development and recurrence of a variety of cancer types. It has been well studied that acute exercise induces mobilization of lymphocytes into the peripheral blood, predominantly comprising of NK cells and antigen-experienced T cells. The mechanisms underlying the clinical benefits of exercise in cancer patients are still unclear. Substantial aspects like antigen specificity of exercise-mobilized T cells or secreted markers have only recently attracted research attention. This study aims to comprehensively understand the characteristics of exercise-mediated T cells at a mechanistic level and therefore lay the foundation to optimize exercise effects in cancer patients.

Methods 23 healthy participants enrolled in our INHALE study underwent a single session of supervised high-intensity exercise on bicycle ergometers in May 2023, with peripheral blood samples collected before exercise (bsl), at 2 minutes post-exercise (ex02), and 60 minutes post-exercise (ex60).

Results The mean age of the cohort was 37 years, the mean BMI 23.37 kg/m2 and the physical activity level 3585 MET-min/wk, as assessed by IPAQ-SF. The participants completed the high-intensity (HIIT) exercise session at a mean of 96.4% of their maximal heart rate and 118.1% of the maximal power on the VO2 max test, respectively. A strong mobilization of natural killer (NK) and T cells was observed at ex02. All cell subsets fell below baseline counts at ex60. Exercise-mobilized CD8+ T cells exhibited a higher proportion of effector memory and terminally differentiated effector memory (TEMRA) T cells, in line with higher frequencies of CD57+, CD95+ and PD-1+ CD8+ T cells post-exercise. The strongest correlation with CD8+ T cell mobilization was found with catecholamine levels, and to a lesser extent with proteins linked to chemotaxis and cytolysis. To assess the T cell specificity dynamics against a panel of common viral epitopes following high-intensity exercise, a DNA-barcoded peptide-MHC multimer assay was conducted. In the context of the most prevalent specificities EBV, HHV-6B, and SARS-CoV-2, virus peptide-specific CD8+ T cells are mobilized by HIIT and markedly egress peripheral blood. This egress may occur to peripheral tissues, where the cells increase immunosurveillance.

Conclusions The INHALE study provides valuable data from a relatively large cohort of 23 healthy participants on the effects of exercise specifically in the T cell compartment. Additionally, this investigation serves as an important physiological reference for our ongoing clinical exercise study in NSCLC patients (HI AIM). Prospectively, understanding exercise-triggered circulating tumor-associated antigen-specific T cells may be used to enhance the anti-tumor immune response.

Acknowledgements This work is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – project number 505368854.

Trial Registration The study is registered under NCT05826496.

Ethics Approval Capital Region’s Ethics Committee approval H-23006672.

Consent Written informed consent was obtained from the patient for publication of this abstract and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.

http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.